US and European Union make progress in trade talks
This article was originally published in Clinica
Executive Summary
Negotiators preparing for trade discussions between the US and the European Union in January say unexpected progress has been made toward settling transatlantic differences on the regulation and inspection of medical devices and pharmaceuticals. The progress emerged from a meeting of the Transatlantic Business Dialogue (TABD), an advisory group on EU-US trade, which met in Chicago on November 9th in advance of next year's summit.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.